Multiple Sclerosis (MS) Is a complex neurodegenerative disease that is currently incurable. The disease can cause problems with balance, muscle control, vision and other basic bodily functions. MS is thought to be an inflammatory autoimmune disease in which the body attacks myelin, a critical component of the nervous system. Myelin forms fatty sheaths around nerves, which protects your nerves and facilitates rapid transmission of information throughout your brain. When this myelin is damaged in MS, it can cause mild to significant physical disabilities(1). The hallmark of MS is symptomatic episodes that occur months or years apart (relapses) followed by times of recovery (remission).
Current approaches to treatment include: 1) prevention of disease progression and reduction in relapse rate 2) treatment of acute exacerbations and 3) treatment of chronic symptoms. FDA approved treatments target neuroinflammation by modulating the immune system but not without significant risks(2). Despite new treatments and technologies, therapies to control inflammation and physical symptoms remain ineffective(2).
Extivita Therapies for Multiple Sclerosis: